跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,216 条关于
“21-hydroxylase”
全部
3,216
临床试验
682
药物
352
机构
104
资讯
2,078
2年前
Phase 3 Trial of Crinecerfont Shows Promise in Treating Pediatric Congenital Adrenal Hyperplasia
去年
FDA Grants Priority Review to Crinecerfont for Congenital Adrenal Hyperplasia
去年
Lundbeck's Lu AG13909 Receives Orphan Drug Designation for Congenital Adrenal Hyperplasia Treatment
去年
FDA Approves Neurocrine's Crenessity (crinecerfont) for Congenital Adrenal Hyperplasia
去年
Crinecerfont Shows Promise in Pediatric Congenital Adrenal Hyperplasia Across All Patient Subgroups
2年前
Crinecerfont Shows Promise in Treating Children with Congenital Adrenal Hyperplasia
去年
Crinetics' Atumelnant Shows Promise in Phase 2 Trial for Congenital Adrenal Hyperplasia
2年前
FDA Grants Breakthrough Therapy Designation to Crinecerfont for Congenital Adrenal Hyperplasia
4个月前
Lundbeck Secures Orphan Drug Designation in Japan for Novel ACTH-Targeting Antibody Asedebart
去年
CRENESSITY Shows Consistent Efficacy Across Pediatric CAH Subgroups While Reducing Glucocorticoid Doses
第 1 页,共 208 页
上一页
下一页